The chances of former shareholders in Celgene missing out on the big pay-out from their contingent value right (CVR) deal with Bristol-Myers Squibb have risen sharply, after the FDA refused to accept ...
Get ready for your aha moment: Every weekday, host Meghna Chakrabarti pierces your news bubble to expose the whole story. Getting answers to the questions that need to be asked, examining our history ...
Throughline is a time machine. Each episode, we travel beyond the headlines to answer the question, "How did we get here?" We use sound and stories to bring history to life and put you into the middle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results